Journal of Pharmacology and Experimental Therapeutics: 361 (2)

Index by author

May 01, 2017; Volume 361,Issue 2

A

Aboutanos, Michel
1. You have access
  Low-Volume Resuscitation for Hemorrhagic Shock: Understanding the Mechanism of PEG-20k
  Valerie Plant, Dan W. Parrish, Ashley Limkemann, Paula Ferrada, Michel Aboutanos and Martin J. Mangino
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 334-340; DOI: https://doi.org/10.1124/jpet.116.239822
Acuña, Claudia
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Alfaro, Jennifer
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Almirez, Ramona G.
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Alpert, Carla
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Amaro, Marina
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Amory, John K.
1. You have access
  Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions
  Jing Jing, Cara Nelson, Jisun Paik, Yoshiyuki Shirasaka, John K. Amory and Nina Isoherranen
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 246-258; DOI: https://doi.org/10.1124/jpet.117.240523
Avila, Patricio
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022

B

Barde, Anup
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Bays, Nathan
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Belmar, Sebastián
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Bernales, Sebastián
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Birnbaum, Morris J.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Bollinger, Eliza
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Boucher, Germaine G.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Bui, Khanh
1. Open Access
  Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation
  Eike Floettmann, Khanh Bui, Mark Sostek, Kemal Payza and Michael Eldon
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 280-291; DOI: https://doi.org/10.1124/jpet.116.239061
Byford, Alan
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723

C

Calabrese, Matthew F.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Cameron, Kimberly O.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Cao, Fengyan
1. You have access
  Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways
  Lijun Tao, Jinyu Yang, Fengyan Cao, Haifeng Xie, Mian Zhang, Yanqing Gong and Chaofeng Zhang
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 268-279; DOI: https://doi.org/10.1124/jpet.116.239137
Cattaneo, Christophe
1. You have access
  Endothelin ET_A Receptor Blockade, by Activating ET_B Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention
  Magali Vercauteren, Frederic Trensz, Anne Pasquali, Christophe Cattaneo, Daniel S. Strasser, Patrick Hess, Marc Iglarz and Martine Clozel
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 322-333; DOI: https://doi.org/10.1124/jpet.116.234930
Chagoya de Sánchez, Victoria
1. You have access
  Functional, Metabolic, and Dynamic Mitochondrial Changes in the Rat Cirrhosis-Hepatocellular Carcinoma Model and the Protective Effect of IFC-305
  Enrique Chávez, María Guadalupe Lozano-Rosas, Mariana Domínguez-López, Gabriela Velasco-Loyden, Jesús Rafael Rodríguez-Aguilera, Concepción José-Nuñez, Marietta Tuena de Gómez-Puyou and Victoria Chagoya de Sánchez
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 292-302; DOI: https://doi.org/10.1124/jpet.116.239301
Chakravarthy, Kalyan
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Chakravarty, Sarvajit
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Chauhan, Shailender
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Chávez, Enrique
1. You have access
  Functional, Metabolic, and Dynamic Mitochondrial Changes in the Rat Cirrhosis-Hepatocellular Carcinoma Model and the Protective Effect of IFC-305
  Enrique Chávez, María Guadalupe Lozano-Rosas, Mariana Domínguez-López, Gabriela Velasco-Loyden, Jesús Rafael Rodríguez-Aguilera, Concepción José-Nuñez, Marietta Tuena de Gómez-Puyou and Victoria Chagoya de Sánchez
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 292-302; DOI: https://doi.org/10.1124/jpet.116.239301
Chiu, Chi-Sung
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Cialdea, Katherine
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Clozel, Martine
1. You have access
  Endothelin ET_A Receptor Blockade, by Activating ET_B Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention
  Magali Vercauteren, Frederic Trensz, Anne Pasquali, Christophe Cattaneo, Daniel S. Strasser, Patrick Hess, Marc Iglarz and Martine Clozel
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 322-333; DOI: https://doi.org/10.1124/jpet.116.234930
Cokorinos, Emily
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Coskran, Timothy M.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925

D

Dandliker, Peter J.
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
DaSilva-Jardine, Paul
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Delgado, Luz
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Deshmukh, Sujal V.
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Dinsmore, Christopher
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Domínguez-López, Mariana
1. You have access
  Functional, Metabolic, and Dynamic Mitochondrial Changes in the Rat Cirrhosis-Hepatocellular Carcinoma Model and the Protective Effect of IFC-305
  Enrique Chávez, María Guadalupe Lozano-Rosas, Mariana Domínguez-López, Gabriela Velasco-Loyden, Jesús Rafael Rodríguez-Aguilera, Concepción José-Nuñez, Marietta Tuena de Gómez-Puyou and Victoria Chagoya de Sánchez
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 292-302; DOI: https://doi.org/10.1124/jpet.116.239301
Dorosh, Lauren
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723

E

Edmonds, David J.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Eldon, Michael
1. Open Access
  Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation
  Eike Floettmann, Khanh Bui, Mark Sostek, Kemal Payza and Michael Eldon
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 280-291; DOI: https://doi.org/10.1124/jpet.116.239061
Elwood, Fiona
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723

F

Ferrada, Paula
1. You have access
  Low-Volume Resuscitation for Hemorrhagic Shock: Understanding the Mechanism of PEG-20k
  Valerie Plant, Dan W. Parrish, Ashley Limkemann, Paula Ferrada, Michel Aboutanos and Martin J. Mangino
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 334-340; DOI: https://doi.org/10.1124/jpet.116.239822
Floettmann, Eike
1. Open Access
  Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation
  Eike Floettmann, Khanh Bui, Mark Sostek, Kemal Payza and Michael Eldon
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 280-291; DOI: https://doi.org/10.1124/jpet.116.239061
Flores, Camila
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Fuentealba, Glenda
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022

G

Gaete, Diana
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Gandhok, Harmeet
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Genung, Nathan E.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Goldenblatt, Peter
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Gong, Yanqing
1. You have access
  Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways
  Lijun Tao, Jinyu Yang, Fengyan Cao, Haifeng Xie, Mian Zhang, Yanqing Gong and Chaofeng Zhang
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 268-279; DOI: https://doi.org/10.1124/jpet.116.239137

H

Hague, Chris
1. You have access
  Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α_1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells
  Dorathy-Ann Harris, Ji-Min Park, Kyung-Soon Lee, Cong Xu, Nephi Stella and Chris Hague
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 219-228; DOI: https://doi.org/10.1124/jpet.116.237255
Harris, Dorathy-Ann
1. You have access
  Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α_1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells
  Dorathy-Ann Harris, Ji-Min Park, Kyung-Soon Lee, Cong Xu, Nephi Stella and Chris Hague
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 219-228; DOI: https://doi.org/10.1124/jpet.116.237255
Hess, Patrick
1. You have access
  Endothelin ET_A Receptor Blockade, by Activating ET_B Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention
  Magali Vercauteren, Frederic Trensz, Anne Pasquali, Christophe Cattaneo, Daniel S. Strasser, Patrick Hess, Marc Iglarz and Martine Clozel
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 322-333; DOI: https://doi.org/10.1124/jpet.116.234930
Hung, David T.
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022

I

Iglarz, Marc
1. You have access
  Endothelin ET_A Receptor Blockade, by Activating ET_B Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention
  Magali Vercauteren, Frederic Trensz, Anne Pasquali, Christophe Cattaneo, Daniel S. Strasser, Patrick Hess, Marc Iglarz and Martine Clozel
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 322-333; DOI: https://doi.org/10.1124/jpet.116.234930
Ikushiro, Shin’ichi
1. You have access
  Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation
  Ayumi Kurita, Yuu Miyauchi, Shin’ichi Ikushiro, Peter I. Mackenzie, Hideyuki Yamada and Yuji Ishii
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 199-208; DOI: https://doi.org/10.1124/jpet.117.240382
Ishii, Yuji
1. You have access
  Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation
  Ayumi Kurita, Yuu Miyauchi, Shin’ichi Ikushiro, Peter I. Mackenzie, Hideyuki Yamada and Yuji Ishii
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 199-208; DOI: https://doi.org/10.1124/jpet.117.240382
Isoherranen, Nina
1. You have access
  Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions
  Jing Jing, Cara Nelson, Jisun Paik, Yoshiyuki Shirasaka, John K. Amory and Nina Isoherranen
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 246-258; DOI: https://doi.org/10.1124/jpet.117.240523
Ivanovska, Irena
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723

J

Jatkar, Aditi
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Jing, Jing
1. You have access
  Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions
  Jing Jing, Cara Nelson, Jisun Paik, Yoshiyuki Shirasaka, John K. Amory and Nina Isoherranen
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 246-258; DOI: https://doi.org/10.1124/jpet.117.240523
José-Nuñez, Concepción
1. You have access
  Functional, Metabolic, and Dynamic Mitochondrial Changes in the Rat Cirrhosis-Hepatocellular Carcinoma Model and the Protective Effect of IFC-305
  Enrique Chávez, María Guadalupe Lozano-Rosas, Mariana Domínguez-López, Gabriela Velasco-Loyden, Jesús Rafael Rodríguez-Aguilera, Concepción José-Nuñez, Marietta Tuena de Gómez-Puyou and Victoria Chagoya de Sánchez
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 292-302; DOI: https://doi.org/10.1124/jpet.116.239301

K

Kalgutkar, Amit S.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Kanno, Stacy
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Kariv, Ilona
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Katus, Hugo A.
1. You have access
  Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP₂-interference
  Christoph Koepple, Daniel Scherer, Claudia Seyler, Eberhard Scholz, Dierk Thomas, Hugo A. Katus and Edgar Zitron
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 209-218; DOI: https://doi.org/10.1124/jpet.116.238287
Klappenbach, Joel
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Koepple, Christoph
1. You have access
  Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP₂-interference
  Christoph Koepple, Daniel Scherer, Claudia Seyler, Eberhard Scholz, Dierk Thomas, Hugo A. Katus and Edgar Zitron
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 209-218; DOI: https://doi.org/10.1124/jpet.116.238287
Kraybill, Brian
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Kreeger, John M.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Kurita, Ayumi
1. You have access
  Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation
  Ayumi Kurita, Yuu Miyauchi, Shin’ichi Ikushiro, Peter I. Mackenzie, Hideyuki Yamada and Yuji Ishii
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 199-208; DOI: https://doi.org/10.1124/jpet.117.240382
Kurumbail, Ravi G.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925

L

Lee, Hyun-Hee
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Lee, Kyung-Soon
1. You have access
  Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α_1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells
  Dorathy-Ann Harris, Ji-Min Park, Kyung-Soon Lee, Cong Xu, Nephi Stella and Chris Hague
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 219-228; DOI: https://doi.org/10.1124/jpet.116.237255
Liby, Karen T.
1. You have access
  Nrf2-Dependent and -Independent Effects of tert-Butylhydroquinone, CDDO-Im, and H₂O₂ in Human Jurkat T Cells as Determined by CRISPR/Cas9 Gene Editing
  Joseph W. Zagorski, Tyler P. Maser, Karen T. Liby and Cheryl E. Rockwell
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 259-267; DOI: https://doi.org/10.1124/jpet.116.238899
Limkemann, Ashley
1. You have access
  Low-Volume Resuscitation for Hemorrhagic Shock: Understanding the Mechanism of PEG-20k
  Valerie Plant, Dan W. Parrish, Ashley Limkemann, Paula Ferrada, Michel Aboutanos and Martin J. Mangino
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 334-340; DOI: https://doi.org/10.1124/jpet.116.239822
Lozano-Rosas, María Guadalupe
1. You have access
  Functional, Metabolic, and Dynamic Mitochondrial Changes in the Rat Cirrhosis-Hepatocellular Carcinoma Model and the Protective Effect of IFC-305
  Enrique Chávez, María Guadalupe Lozano-Rosas, Mariana Domínguez-López, Gabriela Velasco-Loyden, Jesús Rafael Rodríguez-Aguilera, Concepción José-Nuñez, Marietta Tuena de Gómez-Puyou and Victoria Chagoya de Sánchez
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 292-302; DOI: https://doi.org/10.1124/jpet.116.239301

M

Maciejewski, Benjamin S
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Mackenzie, Peter I.
1. You have access
  Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation
  Ayumi Kurita, Yuu Miyauchi, Shin’ichi Ikushiro, Peter I. Mackenzie, Hideyuki Yamada and Yuji Ishii
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 199-208; DOI: https://doi.org/10.1124/jpet.117.240382
Mangino, Martin J.
1. You have access
  Low-Volume Resuscitation for Hemorrhagic Shock: Understanding the Mechanism of PEG-20k
  Valerie Plant, Dan W. Parrish, Ashley Limkemann, Paula Ferrada, Michel Aboutanos and Martin J. Mangino
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 334-340; DOI: https://doi.org/10.1124/jpet.116.239822
Maser, Tyler P.
1. You have access
  Nrf2-Dependent and -Independent Effects of tert-Butylhydroquinone, CDDO-Im, and H₂O₂ in Human Jurkat T Cells as Determined by CRISPR/Cas9 Gene Editing
  Joseph W. Zagorski, Tyler P. Maser, Karen T. Liby and Cheryl E. Rockwell
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 259-267; DOI: https://doi.org/10.1124/jpet.116.238899
McCullagh, Emma
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Miller, Russell A.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Miyauchi, Yuu
1. You have access
  Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation
  Ayumi Kurita, Yuu Miyauchi, Shin’ichi Ikushiro, Peter I. Mackenzie, Hideyuki Yamada and Yuji Ishii
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 199-208; DOI: https://doi.org/10.1124/jpet.117.240382
Monetti, Mara
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925

N

Nayak, Anjan K.
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Nelson, Cara
1. You have access
  Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions
  Jing Jing, Cara Nelson, Jisun Paik, Yoshiyuki Shirasaka, John K. Amory and Nina Isoherranen
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 246-258; DOI: https://doi.org/10.1124/jpet.117.240523

O

Opsahl, Alan C.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925

P

Paik, Jisun
1. You have access
  Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions
  Jing Jing, Cara Nelson, Jisun Paik, Yoshiyuki Shirasaka, John K. Amory and Nina Isoherranen
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 246-258; DOI: https://doi.org/10.1124/jpet.117.240523
Pan, Bo-Sheng
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Park, Ji-Min
1. You have access
  Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α_1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells
  Dorathy-Ann Harris, Ji-Min Park, Kyung-Soon Lee, Cong Xu, Nephi Stella and Chris Hague
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 219-228; DOI: https://doi.org/10.1124/jpet.116.237255
Parrish, Dan W.
1. You have access
  Low-Volume Resuscitation for Hemorrhagic Shock: Understanding the Mechanism of PEG-20k
  Valerie Plant, Dan W. Parrish, Ashley Limkemann, Paula Ferrada, Michel Aboutanos and Martin J. Mangino
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 334-340; DOI: https://doi.org/10.1124/jpet.116.239822
Pasquali, Anne
1. You have access
  Endothelin ET_A Receptor Blockade, by Activating ET_B Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention
  Magali Vercauteren, Frederic Trensz, Anne Pasquali, Christophe Cattaneo, Daniel S. Strasser, Patrick Hess, Marc Iglarz and Martine Clozel
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 322-333; DOI: https://doi.org/10.1124/jpet.116.234930
Patel, Dhananjay
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Payza, Kemal
1. Open Access
  Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation
  Eike Floettmann, Khanh Bui, Mark Sostek, Kemal Payza and Michael Eldon
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 280-291; DOI: https://doi.org/10.1124/jpet.116.239061
Pérez de Arce, Felipe
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Pham, Son M.
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Piesvaux, Jennifer
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Plant, Valerie
1. You have access
  Low-Volume Resuscitation for Hemorrhagic Shock: Understanding the Mechanism of PEG-20k
  Valerie Plant, Dan W. Parrish, Ashley Limkemann, Paula Ferrada, Michel Aboutanos and Martin J. Mangino
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 334-340; DOI: https://doi.org/10.1124/jpet.116.239822
Pujala, Brahmam
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022

Q

Qu, Yujie
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Quinn, Kevin P.
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022

R

Rai, Roopa
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Rajamohan, Francis
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Reyes, Allan
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Rivkin, Alexey
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Rockwell, Cheryl E.
1. You have access
  Nrf2-Dependent and -Independent Effects of tert-Butylhydroquinone, CDDO-Im, and H₂O₂ in Human Jurkat T Cells as Determined by CRISPR/Cas9 Gene Editing
  Joseph W. Zagorski, Tyler P. Maser, Karen T. Liby and Cheryl E. Rockwell
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 259-267; DOI: https://doi.org/10.1124/jpet.116.238899
Rodríguez-Aguilera, Jesús Rafael
1. You have access
  Functional, Metabolic, and Dynamic Mitochondrial Changes in the Rat Cirrhosis-Hepatocellular Carcinoma Model and the Protective Effect of IFC-305
  Enrique Chávez, María Guadalupe Lozano-Rosas, Mariana Domínguez-López, Gabriela Velasco-Loyden, Jesús Rafael Rodríguez-Aguilera, Concepción José-Nuñez, Marietta Tuena de Gómez-Puyou and Victoria Chagoya de Sánchez
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 292-302; DOI: https://doi.org/10.1124/jpet.116.239301
Rolph, Tim
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925

S

Salatto, Christopher T.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Scherer, Daniel
1. You have access
  Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP₂-interference
  Christoph Koepple, Daniel Scherer, Claudia Seyler, Eberhard Scholz, Dierk Thomas, Hugo A. Katus and Edgar Zitron
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 209-218; DOI: https://doi.org/10.1124/jpet.116.238287
Scholz, Eberhard
1. You have access
  Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP₂-interference
  Christoph Koepple, Daniel Scherer, Claudia Seyler, Eberhard Scholz, Dierk Thomas, Hugo A. Katus and Edgar Zitron
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 209-218; DOI: https://doi.org/10.1124/jpet.116.238287
Scott, Mark E.
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Seyler, Claudia
1. You have access
  Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP₂-interference
  Christoph Koepple, Daniel Scherer, Claudia Seyler, Eberhard Scholz, Dierk Thomas, Hugo A. Katus and Edgar Zitron
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 209-218; DOI: https://doi.org/10.1124/jpet.116.238287
Sharma, Vijay K.
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Shavnya, Andre
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Shirasaka, Yoshiyuki
1. You have access
  Physiologically Based Pharmacokinetic Model of All-trans-Retinoic Acid with Application to Cancer Populations and Drug Interactions
  Jing Jing, Cara Nelson, Jisun Paik, Yoshiyuki Shirasaka, John K. Amory and Nina Isoherranen
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 246-258; DOI: https://doi.org/10.1124/jpet.117.240523
Slipetz, Deborah
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Sostek, Mark
1. Open Access
  Pharmacologic Profile of Naloxegol, a Peripherally Acting µ-Opioid Receptor Antagonist, for the Treatment of Opioid-Induced Constipation
  Eike Floettmann, Khanh Bui, Mark Sostek, Kemal Payza and Michael Eldon
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 280-291; DOI: https://doi.org/10.1124/jpet.116.239061
Stella, Nephi
1. You have access
  Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α_1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells
  Dorathy-Ann Harris, Ji-Min Park, Kyung-Soon Lee, Cong Xu, Nephi Stella and Chris Hague
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 219-228; DOI: https://doi.org/10.1124/jpet.116.237255
Strasser, Daniel S.
1. You have access
  Endothelin ET_A Receptor Blockade, by Activating ET_B Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention
  Magali Vercauteren, Frederic Trensz, Anne Pasquali, Christophe Cattaneo, Daniel S. Strasser, Patrick Hess, Marc Iglarz and Martine Clozel
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 322-333; DOI: https://doi.org/10.1124/jpet.116.234930

T

Tang, Hao
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Tao, Lijun
1. You have access
  Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways
  Lijun Tao, Jinyu Yang, Fengyan Cao, Haifeng Xie, Mian Zhang, Yanqing Gong and Chaofeng Zhang
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 268-279; DOI: https://doi.org/10.1124/jpet.116.239137
Tess, David A.
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Thomas, Dierk
1. You have access
  Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP₂-interference
  Christoph Koepple, Daniel Scherer, Claudia Seyler, Eberhard Scholz, Dierk Thomas, Hugo A. Katus and Edgar Zitron
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 209-218; DOI: https://doi.org/10.1124/jpet.116.238287
Trensz, Frederic
1. You have access
  Endothelin ET_A Receptor Blockade, by Activating ET_B Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention
  Magali Vercauteren, Frederic Trensz, Anne Pasquali, Christophe Cattaneo, Daniel S. Strasser, Patrick Hess, Marc Iglarz and Martine Clozel
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 322-333; DOI: https://doi.org/10.1124/jpet.116.234930
Tuena de Gómez-Puyou, Marietta
1. You have access
  Functional, Metabolic, and Dynamic Mitochondrial Changes in the Rat Cirrhosis-Hepatocellular Carcinoma Model and the Protective Effect of IFC-305
  Enrique Chávez, María Guadalupe Lozano-Rosas, Mariana Domínguez-López, Gabriela Velasco-Loyden, Jesús Rafael Rodríguez-Aguilera, Concepción José-Nuñez, Marietta Tuena de Gómez-Puyou and Victoria Chagoya de Sánchez
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 292-302; DOI: https://doi.org/10.1124/jpet.116.239301

U

Upendra, T. V. R.
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022
Ureta, Gonzalo
1. You have access
  Dual Inhibition of Bruton’s Tyrosine Kinase and Phosphoinositide-3-Kinase p110δ as a Therapeutic Approach to Treat Non-Hodgkin’s B Cell Malignancies
  Jennifer Alfaro, Felipe Pérez de Arce, Sebastián Belmar, Glenda Fuentealba, Patricio Avila, Gonzalo Ureta, Camila Flores, Claudia Acuña, Luz Delgado, Diana Gaete, Brahmam Pujala, Anup Barde, Anjan K. Nayak, T. V. R. Upendra, Dhananjay Patel, Shailender Chauhan, Vijay K. Sharma, Stacy Kanno, Ramona G. Almirez, David T. Hung, Sarvajit Chakravarty, Roopa Rai, Sebastián Bernales, Kevin P. Quinn, Son M. Pham and Emma McCullagh
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 312-321; DOI: https://doi.org/10.1124/jpet.116.238022

V

Velasco-Loyden, Gabriela
1. You have access
  Functional, Metabolic, and Dynamic Mitochondrial Changes in the Rat Cirrhosis-Hepatocellular Carcinoma Model and the Protective Effect of IFC-305
  Enrique Chávez, María Guadalupe Lozano-Rosas, Mariana Domínguez-López, Gabriela Velasco-Loyden, Jesús Rafael Rodríguez-Aguilera, Concepción José-Nuñez, Marietta Tuena de Gómez-Puyou and Victoria Chagoya de Sánchez
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 292-302; DOI: https://doi.org/10.1124/jpet.116.239301
Vercauteren, Magali
1. You have access
  Endothelin ET_A Receptor Blockade, by Activating ET_B Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retention
  Magali Vercauteren, Frederic Trensz, Anne Pasquali, Christophe Cattaneo, Daniel S. Strasser, Patrick Hess, Marc Iglarz and Martine Clozel
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 322-333; DOI: https://doi.org/10.1124/jpet.116.234930

W

Ward, Jessica
1. You have access
  Selective Activation of AMPK β1-Containing Isoforms Improves Kidney Function in a Rat Model of Diabetic Nephropathy
  Christopher T. Salatto, Russell A. Miller, Kimberly O. Cameron, Emily Cokorinos, Allan Reyes, Jessica Ward, Matthew F. Calabrese, Ravi G. Kurumbail, Francis Rajamohan, Amit S. Kalgutkar, David A. Tess, Andre Shavnya, Nathan E. Genung, David J. Edmonds, Aditi Jatkar, Benjamin S Maciejewski, Marina Amaro, Harmeet Gandhok, Mara Monetti, Katherine Cialdea, Eliza Bollinger, John M. Kreeger, Timothy M. Coskran, Alan C. Opsahl, Germaine G. Boucher, Morris J. Birnbaum, Paul DaSilva-Jardine and Tim Rolph
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 303-311; DOI: https://doi.org/10.1124/jpet.116.237925
Witter, David J.
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723

X

Xie, Haifeng
1. You have access
  Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways
  Lijun Tao, Jinyu Yang, Fengyan Cao, Haifeng Xie, Mian Zhang, Yanqing Gong and Chaofeng Zhang
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 268-279; DOI: https://doi.org/10.1124/jpet.116.239137
Xu, Cong
1. You have access
  Label-Free Dynamic Mass Redistribution Reveals Low-Density, Prosurvival α_1B-Adrenergic Receptors in Human SW480 Colon Carcinoma Cells
  Dorathy-Ann Harris, Ji-Min Park, Kyung-Soon Lee, Cong Xu, Nephi Stella and Chris Hague
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 219-228; DOI: https://doi.org/10.1124/jpet.116.237255

Y

Yamada, Hideyuki
1. You have access
  Comprehensive Characterization of Mouse UDP-Glucuronosyltransferase (Ugt) Belonging to the Ugt2b Subfamily: Identification of Ugt2b36 as the Predominant Isoform Involved in Morphine Glucuronidation
  Ayumi Kurita, Yuu Miyauchi, Shin’ichi Ikushiro, Peter I. Mackenzie, Hideyuki Yamada and Yuji Ishii
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 199-208; DOI: https://doi.org/10.1124/jpet.117.240382
Yang, Jinyu
1. You have access
  Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways
  Lijun Tao, Jinyu Yang, Fengyan Cao, Haifeng Xie, Mian Zhang, Yanqing Gong and Chaofeng Zhang
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 268-279; DOI: https://doi.org/10.1124/jpet.116.239137

Z

Zagorski, Joseph W.
1. You have access
  Nrf2-Dependent and -Independent Effects of tert-Butylhydroquinone, CDDO-Im, and H₂O₂ in Human Jurkat T Cells as Determined by CRISPR/Cas9 Gene Editing
  Joseph W. Zagorski, Tyler P. Maser, Karen T. Liby and Cheryl E. Rockwell
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 259-267; DOI: https://doi.org/10.1124/jpet.116.238899
Zhang, Chaofeng
1. You have access
  Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways
  Lijun Tao, Jinyu Yang, Fengyan Cao, Haifeng Xie, Mian Zhang, Yanqing Gong and Chaofeng Zhang
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 268-279; DOI: https://doi.org/10.1124/jpet.116.239137
Zhang, Mian
1. You have access
  Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways
  Lijun Tao, Jinyu Yang, Fengyan Cao, Haifeng Xie, Mian Zhang, Yanqing Gong and Chaofeng Zhang
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 268-279; DOI: https://doi.org/10.1124/jpet.116.239137
Zielstorff, Mark
1. You have access
  Evaluation of JAK3 Biology in Autoimmune Disease Using a Highly Selective, Irreversible JAK3 Inhibitor
  Fiona Elwood, David J. Witter, Jennifer Piesvaux, Brian Kraybill, Nathan Bays, Carla Alpert, Peter Goldenblatt, Yujie Qu, Irena Ivanovska, Hyun-Hee Lee, Chi-Sung Chiu, Hao Tang, Mark E. Scott, Sujal V. Deshmukh, Mark Zielstorff, Alan Byford, Kalyan Chakravarthy, Lauren Dorosh, Alexey Rivkin, Joel Klappenbach, Bo-Sheng Pan, Ilona Kariv, Christopher Dinsmore, Deborah Slipetz and Peter J. Dandliker
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 229-244; DOI: https://doi.org/10.1124/jpet.116.239723
Zitron, Edgar
1. You have access
  Dual Mechanism for Inhibition of Inwardly Rectifying Kir2.x Channels by Quinidine Involving Direct Pore Block and PIP₂-interference
  Christoph Koepple, Daniel Scherer, Claudia Seyler, Eberhard Scholz, Dierk Thomas, Hugo A. Katus and Edgar Zitron
  
  Journal of Pharmacology and Experimental Therapeutics May 2017, 361 (2) 209-218; DOI: https://doi.org/10.1124/jpet.116.238287

Main menu

User menu

Search

Index by author

A

Aboutanos, Michel

Acuña, Claudia

Alfaro, Jennifer

Almirez, Ramona G.

Alpert, Carla

Amaro, Marina

Amory, John K.

Avila, Patricio

B

Barde, Anup

Bays, Nathan

Belmar, Sebastián

Bernales, Sebastián

Birnbaum, Morris J.

Bollinger, Eliza

Boucher, Germaine G.

Bui, Khanh

Byford, Alan

C

Calabrese, Matthew F.

Cameron, Kimberly O.

Cao, Fengyan

Cattaneo, Christophe

Chagoya de Sánchez, Victoria

Chakravarthy, Kalyan

Chakravarty, Sarvajit

Chauhan, Shailender

Chávez, Enrique

Chiu, Chi-Sung

Cialdea, Katherine

Clozel, Martine

Cokorinos, Emily

Coskran, Timothy M.

D

Dandliker, Peter J.

DaSilva-Jardine, Paul

Delgado, Luz

Deshmukh, Sujal V.

Dinsmore, Christopher

Domínguez-López, Mariana

Dorosh, Lauren

E

Edmonds, David J.

Eldon, Michael

Elwood, Fiona

F

Ferrada, Paula

Floettmann, Eike

Flores, Camila

Fuentealba, Glenda

G

Gaete, Diana

Gandhok, Harmeet

Genung, Nathan E.

Goldenblatt, Peter

Gong, Yanqing

H

Hague, Chris

Harris, Dorathy-Ann

Hess, Patrick

Hung, David T.

I

Iglarz, Marc

Ikushiro, Shin’ichi

Ishii, Yuji

Isoherranen, Nina

Ivanovska, Irena

J

Jatkar, Aditi

Jing, Jing

José-Nuñez, Concepción

K

Kalgutkar, Amit S.

Kanno, Stacy

Kariv, Ilona